Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence

Go back to Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence

Nevro (NVRO) Tops Q4 EPS by 5c

February 29, 2016 4:43 PM EST

Nevro (NYSE: NVRO) reported Q4 EPS of ($0.51), $0.05 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $32.88 million.

GUIDANCE:

Nevro sees FY2016 revenue of $155-165 million, versus the consensus of $150... More

Nevro (NVRO) CEO to Transition to Role of Executive Chairman; Rami Elghandour Will Assume Role of President and Chief Executive Officer

February 29, 2016 4:39 PM EST

Nevro Corp. (NYSE: NVRO) Board of Directors announced today that Michael DeMane, Nevro's Chief Executive Officer since March 2011, will transition to the role of Executive Chairman of the Board of Directors effective June 1, 2016. Also on that date, Rami Elghandour, Nevro's current President, will assume the role of President and Chief Executive Officer. Mr.... More

Trading Radar for 2/29: Curis (CRIS), Lumber Liquidators (LL), Netlist (NLST), TASER Int'l (TASR) Report

February 26, 2016 3:19 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:

Earnings:

3D Systems (NYSE: DDD) - consensus EPS $0.03
AMC Entertainment (NYSE: AMC) - consensus EPS $0.40
Acadia Pharma (Nasdaq: ACAD) - consensus loss $0.38
Altisource Residential (NYSE: RESI) - consensus EPS $0.18
Ares Management (Nasdaq: ARES) - consensus EPS $0.29
Arqule (Nasdaq: ARQL) - consensus loss... More